跳至主要内容
临床试验/NCT03738566
NCT03738566已完成不适用

Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management: Randomized Controlled Trial

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2018年11月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
26
试验地点
2
主要终点
Number of Endoscopic Interventions

研究概览

简要总结

This study is being done to see which treatment is more effective in improving the difficulty of swallowing. Researchers are comparing self-dilation to endoscopic dilation.

详细描述

Benign esophageal strictures can be challenging condition to treat. The mainstay of treatment is endoscopic dilations. However, 30 to 40% of these strictures recur despite rigorous dilations. Although a consensus definition does not exist, a stricture is typically termed as a refractory benign esophageal stricture (RBES), when there is a failure to maintain luminal patency after at least 5 endoscopic dilations.

Patients with RBES are extremely difficult to manage and the current armamentarium includes repeated endoscopic dilations, corticosteroid or mitomycin C injections, incisional therapy, and/ or temporary stent placement. These procedures are costly, their efficacy can be short-lived, and are associated with great burden both for the patient and clinician.

Esophageal self -dilation therapy (ESDT) is where the patient learns to pass a polyvinyl dilator orally on a routine basis. In past, smaller studies, ESDT appears to be effective for RBES, reducing the number of endoscopic dilations from an average of 21.7 to an average of 1.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Refractory benign esophageal stricture defined as an esophageal stricture with persistent dysphagia despite undergoing 5 endoscopic dilations within a 1 year period. Persistent dysphagia will be considered if patients has solid food dysphagia at least once a week

排除标准

  • Patient with malignant esophageal stricture
  • Angulated stricture which prevents safe passage of Maloney dilator in office setting
  • In ability to achieve an esophageal diameter of 10 mm with endoscopic dilation
  • Known significant esophageal motor disorder (i.e. achalasia, aperistalsis, functional obstruction, jackhammer, distal esophageal spasm)*
  • The presence of esophageal stent
  • Inability to learn self-dilation secondary to blindness or cognitive dysfunction
  • Use of chronic anticoagulants

结局指标

主要结局

Number of Endoscopic Interventions

时间窗: 6 months following serial dilation

Number of endoscopies required in a 6 month interval in subjects who achieved at least a 10-12 mm esophageal diameter during serial dilation for refractory benign esophageal stricture (RBES) and were subsequently treated with ESDT versus standard clinical care

次要结局

  • Mayo Dysphagia Questionnaire (MDQ-30) at Baseline(Baseline)
  • Length of Days Intervention Free(6 months)
  • Mayo Dysphagia Questionnaire (MDQ-30) at 12 Months(12 months)
  • Clinically Significant Adverse Events(12 months)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeffrey A Alexander

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验